American National Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $130K | Hold |
2,250
| – | – | 0.01% | 292 |
|
|
2026
Q1 | $136K | Sell |
2,250
-271
| -11% | -$15.8K | 0.01% | 269 |
|
|
2025
Q4 | $136K | Buy |
2,521
+120
| +5% | +$5.77K | 0.01% | 276 |
|
|
2025
Q3 | $108K | Buy |
2,401
+84
| +4% | +$3.92K | 0.01% | 284 |
|
|
2025
Q2 | $107K | Buy |
2,317
+342
| +17% | +$16.8K | 0.01% | 301 |
|
|
2025
Q1 | $120K | Buy |
1,975
+75
| +4% | +$4.37K | 0.01% | 255 |
|
|
2024
Q4 | $107K | Buy |
1,900
+300
| +19% | +$16.8K | 0.01% | 252 |
|
|
2024
Q3 | $82.8K | Sell |
1,600
-1,200
| -43% | -$56.3K | 0.01% | 270 |
|
|
2024
Q2 | $116K | Hold |
2,800
| – | – | 0.01% | 250 |
|
|
2024
Q1 | $152K | Hold |
2,800
| – | – | 0.02% | 219 |
|
|
2023
Q4 | $144K | Sell |
2,800
-2,874
| -51% | -$151K | 0.02% | 200 |
|
|
2023
Q3 | $329K | Buy |
5,674
+1,200
| +27% | +$73.5K | 0.06% | 139 |
|
|
2023
Q2 | $286K | Sell |
4,474
-10
| -0.2% | -$671 | 0.05% | 140 |
|
|
2023
Q1 | $311K | Sell |
4,484
-280
| -6% | -$19.7K | 0.06% | 134 |
|
|
2022
Q4 | $343K | Buy |
4,764
+777
| +19% | +$58.6K | 0.07% | 116 |
|
|
2022
Q3 | $283K | Buy |
3,987
+1,642
| +70% | +$119K | 0.07% | 108 |
|
|
2022
Q2 | $181K | Hold |
2,345
| – | – | 0.04% | 115 |
|
|
2022
Q1 | $171K | Sell |
2,345
-1,369
| -37% | -$91.9K | 0.03% | 125 |
|
|
2021
Q4 | $232K | Sell |
3,714
-811
| -18% | -$47.6K | 0.05% | 117 |
|
|
2021
Q3 | $268K | Sell |
4,525
-50
| -1% | -$3.29K | 0.06% | 99 |
|
|
2021
Q2 | $306K | Sell |
4,575
-310
| -6% | -$20.2K | 0.07% | 95 |
|
|
2021
Q1 | $308K | Sell |
4,885
-410
| -8% | -$25.5K | 0.07% | 90 |
|
|
2020
Q4 | $328K | Sell |
5,295
-5,495
| -51% | -$338K | 0.08% | 82 |
|
|
2020
Q3 | $651K | Buy |
10,790
+5
| +0% | +$301 | 0.19% | 64 |
|
|
2020
Q2 | $634K | Sell |
10,785
-430
| -4% | -$25.7K | 0.2% | 58 |
|
|
2020
Q1 | $625K | Buy |
11,215
+10,350
| +1,197% | +$633K | 0.25% | 53 |
|
|
2019
Q4 | $56K | Buy |
+865
| New | +$49.5K | 0.02% | 126 |
|
|
2019
Q1 | – | Sell |
-373
| Closed | -$19K | – | 155 |
|
|
2018
Q4 | $19K | Sell |
373
-5,178
| -93% | -$278K | 0.01% | 131 |
|
|
2018
Q3 | $345K | Sell |
5,551
-196
| -3% | -$11.6K | 0.1% | 95 |
|
|
2018
Q2 | $318K | Sell |
5,747
-249
| -4% | -$13.4K | 0.09% | 110 |
|
|
2018
Q1 | $379K | Sell |
5,996
-523
| -8% | -$33.6K | 0.11% | 99 |
|
|
2017
Q4 | $399K | Buy |
6,519
+930
| +17% | +$58.2K | 0.11% | 97 |
|
|
2017
Q3 | $356K | Buy |
5,589
+3,445
| +161% | +$201K | 0.11% | 93 |
|
|
2017
Q2 | $119K | Buy |
2,144
+225
| +12% | +$12.2K | 0.04% | 119 |
|
|
2017
Q1 | $104K | Buy |
1,919
+508
| +36% | +$27.9K | 0.03% | 125 |
|
|
2016
Q4 | $82K | Buy |
1,411
+1,141
| +423% | +$62.4K | 0.03% | 130 |
|
|
2016
Q3 | $15K | Hold |
270
| – | – | 0.01% | 202 |
|
|
2016
Q2 | $20K | Buy |
+270
| New | +$19.1K | 0.01% | 181 |
|
Other funds holding BMY
AIM
FWIA
DLA
SLAM
American National Bank & Trust's BMY Position: Q2 2026 in Review
American National Bank & Trust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 2,250 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #292.
American National Bank & Trust first reported a position in BMY in Q2 2016 and has held it in 38 quarters since. The position peaked at $651K in Q3 2020. 994 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- American National Bank & Trust held 2,250 shares of Bristol-Myers Squibb worth $130K as of Q2 2026.
- American National Bank & Trust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of American National Bank & Trust's portfolio in Q2 2026, its #292 holding.
- American National Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 38 quarters since.
- American National Bank & Trust's Bristol-Myers Squibb position peaked at $651K in Q3 2020.
- 994 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.